| FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application (NCT06270394) | The First Affiliated Hospital of Anhui Medical University | 2022-04-28 |
| BBPA PET/CT in Patients With Malignant Tumors (NCT05987098) | Peking Union Medical College Hospital | 2021-03-22 |
| CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors (NCT04702841) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2020-06-03 |
| Clinical Study of Pretreatment PET/CT Parameters for Predicting the Efficacy of 125I Seed Implantation in the Treatment of Malignant Tumors (NCT07208487) | Jiangxi Provincial Cancer Hospital | 2019-01-01 |
| Restricted Calorie Ketogenic Diet as a Treatment in Malignant Tumors (NCT03160599) | Second Affiliated Hospital of Guangzhou Medical University | 2018-03-01 |
| Usefulness of Gadovist-enhanced FLAIR Imaging (NCT05293990) | Ryoo, In Seon | 2017-02-02 |
| Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors (NCT02534506) | Bristol-Myers Squibb | 2015-11-06 |
| Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET (NCT03542773) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-06 |
| Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer (NCT02041871) | Assistance Publique - Hôpitaux de Paris | 2013-09-01 |
| An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors (NCT01678690) | InnoPharmax Inc. | 2012-08-01 |
| Additive Homeopathy in Cancer Patients (NCT01509612) | Medical University of Vienna | 2012-02-01 |
| Chinese Population Health and Multimorbidity Study (NCT07026370) | China-Japan Friendship Hospital | 2011-01-01 |
| The Effect of Ketogenic Diet on Malignant Tumors- Recurrence and Progress (NCT01092247) | Tel-Aviv Sourasky Medical Center | 2010-03-01 |
| Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer (NCT00165100) | Dana-Farber Cancer Institute | 2000-01-01 |
| Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents (NCT00412503) | Gustave Roussy, Cancer Campus, Grand Paris | |